key: cord-0961571-0bwzvxzg
authors: Palomino-Tapia, Victor; Mitevski, Darko; Inglis, Tom; van der Meer, Frank; Abdul-Careem, Mohamed Faizal
title: Molecular Characterization of Hemorrhagic Enteritis Virus (HEV) Obtained from Clinical Samples in Western Canada 2017–2018
date: 2020-08-26
journal: Viruses
DOI: 10.3390/v12090941
sha: 9e3ac4b21c99bce1776be3a6d87f9aa719d905f3
doc_id: 961571
cord_uid: 0bwzvxzg

Hemorrhagic enteritis virus (HEV) is an immunosuppressive adenovirus that causes an acute clinical disease characterized by hemorrhagic gastroenteritis in 4-week-old turkeys and older. Recurrent incidence of secondary infections (e.g., systemic bacterial infections, cellulitis, and elevated mortality), may be associated with the presence of field-type HEV in Canadian turkey farms. We speculate that field-type HEV and vaccine/vaccine-like strains can be differentiated through analysis of the viral genomes, hexon genes, and the specific virulence factors (e.g., ORF1, E3, and fib knob domain). Nine out of sixteen spleens obtained from cases suspected of immunosuppression by HEV were analyzed. The limited data obtained showed that: (1) field-type HEV circulates in many non-vaccinated western Canadian flocks; (2) field-type HEV circulates in vaccinated flocks with increased recurrent bacterial infections; and (3) the existence of novel point mutations in hexon, ORF1, E3, and specially fib knob domains. This is the first publication showing the circulation of wild-type HEV in HEV-vaccinated flocks in Western Canada, and the usefulness of a novel procedure that allows whole genome sequencing of HEV directly from spleens, without passaging in cell culture or passaging in vivo. Further studies focusing more samples are required to confirm our observations and investigate possible vaccination failure.

Hemorrhagic enteritis virus (HEV) or Turkey siadenovirus A, a member of the family Adenoviridae, genus Siadenovirus, is a ubiquitous poultry pathogen. HEV has a linear, double-stranded DNA genome of 26.6 kilo base pairs (kb) [1] and codes for eight open reading frames (ORFs) distributed in two clusters [2] . Within these, the hexon and fiber proteins are important for their involvement in cell attachment and entry, plus the induction of neutralizing antibodies and protection against the disease [3] [4] [5] . HEV is the etiological agent of hemorrhagic enteritis (HE), a disease characterized by immunosuppression in turkeys of >4-weeks of age. The disease has two presentations: (1) clinical disease consisting of depression, gastrointestinal hemorrhages, and transient immunosuppression followed by increased mortality (up to 80% for highly virulent strains due to blood loss and secondary currently the only vaccine type available in Canada; and (c) inactivated vaccines, used more commonly in countries where no live vaccines are available [8, 12] . Use of either live vaccine variants (a and b) will induce seroconversion and lead to protection against virus challenge [37] , however, the splenic vaccines induce a strong and immediate immunity and can be given as emergency vaccine during an outbreak [8] . Because of this, splenic vaccines are regarded as a more potent vaccine compared to the tissue culture vaccine and requires less revaccinations in the field to achieve a protective antibody titer [8, 36] .

The Canadian turkey meat industry, with~160 million kg of turkey meat in 2019 [38] , is small in comparison with other countries, such as the United States (3.25 billion kg in 2019) [39] . This is of importance as the access to some vaccines, drugs, and ELISA kits is limited due to market constrains. In Canada, the tissue culture vaccine is the only vaccine approved for HEV control and is applied once, using a full dose (≥10 2.6 TCID 50 ) between 3.5-6 weeks of age, or twice, using a lower dose (e.g., 2/3 of a dose or ≥10 2.4 TCID 50 ) at days 25 and 35. This strategy is designed to reduce field HEV circulation in susceptible birds by immunizing birds with low maternal antibodies with the first vaccine delivery (day 25) , and to infect those who were not immunized at the first vaccination due to high levels of neutralizing maternal antibodies or low vaccine intake (day 35). In addition, some farmers rely on circulation and protection generated by field avirulent strains and will, therefore, not vaccinate as there is no manifestation of clinical disease, overlooking the immunosuppressive potential of these field HEV viruses.

Recently, several virulence factors of HEV were identified (i.e., hexon, open reading frame 1 (ORF1), E3, and fib knob domain) [12, 40] . HEV variants containing these factors are circulating in vaccinated flocks leading to subclinical infections [12, 41] . Our objective was to characterize these HEV-positive samples based on whole genome sequencing and/or gene sequences (i.e., hexon, ORF1, E3, fib knob domain) for determination of HEV origin.

Between July 2017-September 2018, a total of 16 spleen samples from Alberta (AB), British Columbia (BC), and Ontario (ON) were collected from turkey clinical cases submitted to Poultry Health Services (PHS) (Airdrie, AB, Canada), a private veterinary practice, by concerned growers with commercial turkey flocks experiencing increased mortality or secondary bacterial infections when compared with industry average, management guides, and/or current literature [42, 43] . The clinical cases were characterized by cellulitis, systemic bacterial infection, and gangrenous dermatitis ( Figure 1 ). Animals aged 44-117 days (average 76 days) were subjected to necropsy and sample collection at the post-mortem facility at the Veterinary Professional Centre (VPC) (Airdrie, AB, Canada).

Of the 16 spleen samples, 9 were HEV-positive by qPCR method [44] , which was conducted at the Institute for Applied Poultry Technologies (IAPT). The positive samples were aliquoted in 1.5 mL tubes and stored at −80 • C until further processing. Moreover, samples from two commercially-available HE vaccines, namely Oralvax HE (Intervet Inc., Merck Animal Health, Omaha, NE, USA), and H.E. Vac (Arko Laboratories, LTD., Jewell, IA, USA) were obtained from PHS, aliquoted, and stored at −80 • C until further processing (Table 1) .

Spleen samples added to sterile tubes prefilled with 1.0 mm zirconium beads (Benchmark Scientific Sayreville, NJ, USA) on ice, and homogenized (BeadBug, Benchmark Scientific, Sayreville, NJ, USA) during three series of 30 s each at 300 RPM. Samples were kept on ice for 3 min in between series. Following disruption, the samples were centrifugated at 7500× g for 20 min at 4 • C and the supernatant filtered using a 0.2 µM syringe filter (Millipore Sigma, Burlington, MA, USA) and kept on ice for further processing. A purification method using ultracentrifugation technique with Optiprep as an iodixanol gradient was used to purify and concentrate HEV [45, 46] . Briefly, the technique was adapted by adjusting the volumes for use with 3.3 mL ultracentrifuge tubes (Optiseal, Beckman Coulter, Fullerton, CA, USA). The highest concentration of virus genome [47] in relation of concentration of host genome [48] was detected by qPCR on phases 8 and 9 (area between 25% iodixanol and 40% iodixanol) and those were collected and processed for DNA extraction.

Total DNA was extracted from reconstituted vaccine vials, and ultracentrifugation phases using a QIAamp DNA Mini Kit according to manufacturers' instruction (Qiagen, Valencia, CA, USA). Invitrogen Platinum SuperFi PCR Master Mix (ThermoFisher Scientific, Waltham, MA, USA) was used for whole genome amplification, while Platinum Hot Start Taq PCR Master Mix (2×) (ThermoFisher Scientific, Waltham, MA, USA) was used for ORF1, E3, and fib knob gene amplification. Due to the high level of host DNA (nuclear and mitochondrial) in the spleen, low levels of HEV virus in persistently-infected spleens due to HEV seroconversion of the flock at the end of production [20] , and multiplex Illumina sequencing, it was not possible to obtain the entire HEV genome without pre-amplification of the sample. genome without pre-amplification of the sample.

The entire HEV genome was amplified using the primers: THEV-Whole-F1, and THEV-Whole-R1 (Table 2) targeting conserved parts at the N and C terminus of the viral genome. The reaction consisted of 1 µ M forward primer THEV-Whole-F1, 1 µ M reverse primer THEV-Whole-R1, 12.5 µ L 2× Platinum Superfi and 10 µ L of DNA template for a total of 25 µ L reaction mix. PCR thermocycler conditions consisted of opening denaturation (95 °C, 2 min) and 35 cycles of 95 °C for 10 s, 59 °C for 10 s, 68 °C for 14 min, and a terminal extension (68 °C, 5 min) resulting in a 26.1 kb amplicon. Following clean up (ExoSAP-IT Express PCR Product Cleanup, Applied Biosystems, Santa Clara, CA, USA) and quantification (Nanodrop 1000, ThermoScientific, Wilmington DE, USA) the DNA was submitted for next generation sequencing (NGS) using a Nextera XT library and the v3600 cartridge (MiSeq, Illumina, San Diego, CA, USA) at the Université de Montréal, QC, Canada. Sanger sequencing for ORF1, E3, and Fib genes using primers on Table 2 , was used to confirm NGS data, and for the two sequences which render incomplete NGS (17-0495; and 18-0430). . This case was submitted due to elevated mortality in a flock without hemorrhagic enteritis virus (HEV) vaccination. The HEV sequence recovered from the spleen was found to be different from vaccine strains and to have missense mutations on the three virulence factors described by [40] , and in the hexon protein.

Airsacculitis lesions can be observed in (a,b); while pericarditis lesions can be observed in (c). Escherichia coli was isolated from pericardium and spleen.

The entire HEV genome was amplified using the primers: THEV-Whole-F1, and THEV-Whole-R1 (Table 2) targeting conserved parts at the N and C terminus of the viral genome. The reaction consisted of 1 µM forward primer THEV-Whole-F1, 1 µM reverse primer THEV-Whole-R1, 12.5 µL 2× Platinum Superfi and 10 µL of DNA template for a total of 25 µL reaction mix. PCR thermocycler conditions consisted of opening denaturation (95 • C, 2 min) and 35 cycles of 95 • C for 10 s, 59 • C for 10 s, 68 • C for 14 min, and a terminal extension (68 • C, 5 min) resulting in a 26.1 kb amplicon. Following clean up (ExoSAP-IT Express PCR Product Cleanup, Applied Biosystems, Santa Clara, CA, USA) and quantification (Nanodrop 1000, ThermoScientific, Wilmington DE, USA) the DNA was submitted for next generation sequencing (NGS) using a Nextera XT library and the v3600 cartridge (MiSeq, Illumina, San Diego, CA, USA) at the Université de Montréal, QC, Canada. Sanger sequencing for ORF1, E3, and Fib genes using primers on Table 2 , was used to confirm NGS data, and for the two sequences which render incomplete NGS (17-0495; and 18-0430). Samples which rendered an incomplete whole genome sequencing were subjected to Sanger Sequencing of the ORF1, E3, and Fib genes. The ORF1 gene (1508 bp out of 1553 bp) was amplified using 1 set of primers (Alkie-HEV-ORF1-F1, and Alkie-HEV3'Rev) resulting in a 1508 bp amplicon. An additional primer was used for sequencing (HEV3'For-951) ( Table 2 ). The reaction for ORF1, E3, and Fib consisted of 5 µM forward primer, 5 µM reverse primer, 12.5 µL 2x Master Mix, 7.5 µL of nuclease-free H2O, and 2.5 µL of DNA template for a total of 25 µL reaction mix. PCR thermocycler conditions consisted of initial denaturation (94 • C, 3 min) and 30 cycles of 94 • C for 30 s, annealing for 30 s, 72 • C for extension, and a final extension (68 • C, 7 min). Annealing temperatures and extension times specific to each primer pair can be found in Table 2 .

The PCR fragments were cleaned with E.Z.N.A. Gel Extraction Kit (Omega Bio-tek Inc., Norcross, GA, USA) and Sanger sequenced using primers depicted in Table 1 (University of Calgary, Core DNA services, Calgary, AB, Canada). Hexon gene comparisons were done only using sequences obtained using NGS (Table 3) , both Sanger and NGS derived sequences where used for the analysis of the other genes. Reference strains used are shown in Table 3 .

NGS short reads were mapped to the splenic vaccine strain (Dindoral SPF; Merial GmbH, Hallbergmoos, Germany) (GenBank accession #AY849321.1) [40, 41] under App Map function on CLC Genomics Workbench v 12.0.2 (Qiagen, Valencia, CA, USA) using default settings, and complemented using Geneious assembler v10.2.6 (Biomatters LTD., Auckland, New Zealand) [49] . Whole genome sequences were aligned with MAFFT v7.450 [50, 51] , and phylogenetic trees were generated using Randomized Axelerated Maximum Likelihood (RAxML) v8.2.11 by applying the nucleotide model GTR+gamma [52] . Hexon, ORF1, E3, and fib knob domain nucleotide and amino acid alignments were performed using Clustal Omega v1.2.2., and phylogenetic trees were generated using RAxML applying the protein model BLOSUM62+gamma. All the sequences were deposited in GenBank (Table 3) . Fib knob domain sequences were further evaluated using both the NetNGlyc (http: //www.cbs.dtu.dk/services/NetNGlyc/) and NetOGlyc (http://www.cbs.dtu.dk/services/NetOGlyc/) online prediction services (DTU Bioinformatics, Department of Bio and Health Informatics, DTU Health Tech, Lyngby, Denmark). Structural locations of amino acid mutations on 3-D structure of published fowl adenovius-1 (FAdV-1) hexon protein (PDB code 2INY [53] ), human adenovirus (HAdV) 2 and 5 (PDB codes 1P2Z, and 1P30 [54, 55] ), and HEV fib knob domain (PDB code 4CW8 [4] ), were carried out using PYMOL v.4.6.0 (Shrödinger LLC, Cambridge MA, USA). 

The complete genome sequences of HEV positive samples with their respective GenBank number and publication are shown in Table 3 , whereas genome size and classification are shown in Table 1 Table S1 ). Upon amino acid alignment analysis of the whole genome sequences, amino acid differences in structural proteins were located in the hexon (two amino acid changes) and fiber (eight amino acid changes) proteins. Phylogenetic trees (Figures 2-4) showed that most of the sequences differed from the vaccine sequences included in the analysis (seven out of nine).

Viruses 2020, 12, x FOR PEER REVIEW 11 of 25

Using the NGS sequences, thirteen single-point mutations were located in the hexon gene (2721 bp) of which 11 were silent. Two non-synonymous mutations consisted of a ntA231C (aaE77D) on 18-0665, and a ntG2598C (aaE866D) mutation in H.E. Vac, Oralvax HE and vaccine-like sequences 18-0943-AB-2018 and 18-1234-AB-2018 (Supplement Table S1 ) were sequenced in this study. The phylogenetic tree in Figure 2b clusters in one branch all commercial vaccines and the HEV sequences 18-0943-AB-2018, and 18-1234-AB-2018.

There is no 3D crystalized molecular structure for HEV hexon protein on which test or analyze the location of these mutations. Although amino acid identities between HAdV-2, HAdV-5, and FAdV-1 range between 47.8-51.36% identity, the overall structure is similar between these viruses consisting on trimers of protein II distributed as three separate "towers" [56] . The location of the mutations was tested on available 3D structures on hexon proteins of HAdV-2, HAdV-3, and FAdV-1 using PYMOL. Both mutations, A231C (aaE77D), and G2598C (aaE866D), were speculated to be located at the bottom of the densely packed pedestal regions (P1, P2) in contact with the penton base found in the capsid interior surface [57, 58] . Table 3 , and Supplement Table S1 Sequences in bold green are the vaccines sequences derived in the present study, bold red are sequences derived from non-vaccinated flocks, and bold blue from vaccinated flocks. Sequences obtained in this study are marked with a black asterisk. GenBank accession numbers and naming structure can be found at Table 3 .

Comparison between all previously published ORF1 sequences [40, 41] and those obtained from the current work showed the presence of several unique and shared mutations. A number of mutations (n = 39) were detected, of which 17 were synonymous and 22 were non-synonymous (Supplement Table S1 ). Some mutations were detected in both vaccine sequences (ntG1485A; aaQ495R) and in German sequences obtained from vaccinated flocks suspected to have subclinical Table 3 , and Supplement Table S1 Sequences in bold green are the vaccines sequences derived in the present study, bold red are sequences derived from non-vaccinated flocks, and bold blue from vaccinated flocks. Sequences obtained in this study are marked with a black asterisk. GenBank accession numbers and naming structure can be found at Table 3 . Viruses 2020, 12, x FOR PEER REVIEW 13 of 25 Figure 3 . ORF1 maximum likelihood (ML) tree. Sequences shows all ORF1 HEV sequences previously published in GenBank, and those obtained in the present project. Sequences in bold green were obtained from vaccines in the present study, bold red from non-vaccinated flocks, and bold blue from vaccinated flocks. Sequences obtained in this study are marked with a black asterisk. GenBank accession numbers and naming structure can be found at Table 3 . Sequences shows all ORF1 HEV sequences previously published in GenBank, and those obtained in the present project. Sequences in bold green were obtained from vaccines in the present study, bold red from non-vaccinated flocks, and bold blue from vaccinated flocks. Sequences obtained in this study are marked with a black asterisk. GenBank accession numbers and naming structure can be found at Table 3 . were obtained from vaccines in the present study, bold red from non-vaccinated flocks, and bold blue from vaccinated flocks. Sequences obtained in this study are marked with a black asterisk. GenBank accession numbers and naming structure can be found at Table 3 .

Using the NGS sequences, thirteen single-point mutations were located in the hexon gene (2721 bp) of which 11 were silent. Two non-synonymous mutations consisted of a ntA231C (aaE77D) on 18-0665, and a ntG2598C (aaE866D) mutation in H.E. Vac, Oralvax HE and vaccine-like sequences 18-0943-AB-2018 and 18-1234-AB-2018 (Supplement Table S1 ) were sequenced in this study. The phylogenetic tree in Figure 2b clusters in one branch all commercial vaccines and the HEV sequences 18-0943-AB-2018, and 18-1234-AB-2018.

There is no 3D crystalized molecular structure for HEV hexon protein on which test or analyze the location of these mutations. Although amino acid identities between HAdV-2, HAdV-5, and FAdV-1 range between 47.8-51.36% identity, the overall structure is similar between these viruses consisting on trimers of protein II distributed as three separate "towers" [56] . The location of the mutations was tested on available 3D structures on hexon proteins of HAdV-2, HAdV-3, and FAdV-1 using PYMOL. Both mutations, A231C (aaE77D), and G2598C (aaE866D), were speculated to be located at the bottom of the densely packed pedestal regions (P1, P2) in contact with the penton base found in the capsid interior surface [57, 58] .

Comparison between all previously published ORF1 sequences [40, 41] and those obtained from the current work showed the presence of several unique and shared mutations. A number of mutations (n = 39) were detected, of which 17 were synonymous and 22 were non-synonymous (Supplement Table S1 ). Some mutations were detected in both vaccine sequences (ntG1485A; aaQ495R) and in German sequences obtained from vaccinated flocks suspected to have subclinical HE with increased mortality and higher incidence of Escherichia coli infections (Cases 7, 8, 12, and 17) [41] (ntG1274A; aaI425V) (Supplement Table S1 ). The phylogenetic tree in Figure 3 shows ORF1 genes of virus 18-1234-AB-2018; 18-0943-AB-2018; and 18-0665-AB-2018 clustering with ORF1 sequences derived from vaccine strains, ORF1 sequences consist of a separate group.

Eight-point mutations were located in the E3 gene (903 bp), of which five were non-synonymous. Some point mutations were common to many sequences, such as ntC497A (aaP166H), which included most US isolates from Virginia, and ntA517C (aaT173P), which included some vaccine and vaccine-like sequences (Supplement Table S1 ). The phylogenetic tree in Figure 4a shows sequences 18-1234-AB-2018; 18-0943-AB-2018; and 18-0665-AB-2018 clustering together with vaccine strains, while all the other sequences clustered in a separate group.

Ten point mutations were located in the fib knob domain, and similarly to previous research, none of them was silent [40] (Supplement Table S1 ). None of the four non-synonymous mutations present in the Canadian sequences was shared with previously published strains from US and Israel [40] . These corresponded to: A ntC214A (aaR72S); a ntG252T (aaL84F); a ntG401A (aaG134D); and a ntG414T (aaM138I). The phylogenetic tree in Figure 4b shows sequences 18-1234-AB-2018; and 18-0943-AB-2018 clustering together with vaccine strains, while all the other sequences clustered apart from vaccine strains. There is a 3D crystalized molecular structure for HEV fib knob domain on which to analyze the location of these mutations. The amino acid sequences analyzed shared an identity of 97.58-100%. All these mutations can be found in the most exterior part of the domain; three of them were shown to be part of linear loops on the exposed surface of the domain (ntC214A (aaR72S); ntG252T (aaL84F); ntG401A (aaG134D); and the last one, ntG414T (aaM138I), was found to be part of a beta sheet that is also exposed (See Figure 5) . Some non-synonymous mutations on the Canadian sequences could be found in the same loop/area than other mutations present in virulent sequences from USA and Israel (See Figure 5 ). 

Twelve-point mutations, a four-nucleotide change, and a three-nucleotide insertion were located in the pTP gene, from which seven corresponded to non-synonymous mutations at aa296, 362, 460, 521, 522-523, 524, and 529. Interestingly, the non-synonymous mutations corresponding to 521-524 are unique to the commercial vaccines and vaccine-like sequences analyzed (Supplement Table S1 ).

The sequences included in each of the phylogenetic trees can be observed on Table 3 . The single point mutations are given in Supplement Table S1 . The sequences studied on this project, in comparison to the H.E. Vac, and Oralvax were found to share: (a) 99.0% to 99.9% nucleotide identity in whole genome sequence ( Figure 2a) ; (b) 99.7% to 100% aa identity in hexon gene ( Figure 2b) ; (c) 99.0% to 99.8% aa identity in the ORF1 gene ( Figure 3 ); (d) 99.3% to 100% aa identity in E3 gene ( Figure 4a) ; and (e) 98.8% to 100% aa identity in the fib knob domain (Figure 4b ).

Twenty-two aa sequences of fib knob domain obtained in this study and previously published were subjected to analysis by the NetOGlyc Server 4.0 service software [59] . This analysis predicted 6 O-glycosylation sites at amino acids 13, 18, 19, 22, 24, and 26 with tight scores within each site in the sequences regarded as vaccine or vaccine-like ( Table 3 ). The same glycosylation spots were located when most of the field strains were analyzed, however higher score variations within each glycosylation areas were found in comparison with the vaccine and vaccine-like sequences. Two sequences, 18-0430, and Virulent-IL-1998, were found to have one extra site at amino acid 10 for a total of seven O-glycosylation sites. Differences with the vaccine profile are marked in red and showed in Table 4 . 

Twenty-two amino acid sequences of fib knob domain obtained in this study and previously published were subjected to analysis by the NetNGlyc Server 1.0 service software [59] . This analysis predicted 10 N-glycosylation sites at amino acids 32, 61, 67, 73, 89, 90, 97, 117, 118, 133, 135, 143 , and 148 in the sequences regarded as vaccine or vaccine-like (Table 5) . Comment "PRO-X1" on the side of a probable glycosylation site, refers to when a proline is located after an asparagine, deeming highly unlikely that the asparagine get glycosylated due to conformational limitations. The Sequon ASN-XAA-SER/THR comment refers to a sequence of consecutive amino acids that is highly likely to get glycosylated ( Table 5) Table 5 . 143-NHVP 0.1038 (9/9) -148-NIKM 0.5943 (6/9) + a Pro-X1: When a Pro residue is located immediately after an Asn residue. Most likely the Asn is not glycosylated due to conformational limitations. b Sequon ASN-XAA-SER/THR indicates a sequence of consecutive amino acids where a polysaccharide can attach. c N-Glyc results: Any potential location crossing the threshold of 0.5 would represent a predicted glycosylated site. Potential of N-glycosylation predicted site is predicted as low "+" or strong "++", "+++" potential; whereas scores with "-", "-", and "-" indicate that the site is most likely not glycosylated. Glycosylation pattern different from H.E. Vac and Oralvax HE, are underlined in bold.

In the present study, whole genome phylogenetic analysis shows the separation of seven whole genome field sequences into two clusters: (1) the first (Cluster 1) considering vaccine and vaccine-like strains (99.82-99.96% nt similarity), and (2) Cluster 2 (99.71-99.98%), including virulent and suspected-virulent strains together with the splenic vaccine, which is not commercially available in Canada. Similarly, as with previous publications, all major ORFs were located as expected [2, 40] . As in previous research [6, 40, 41] , no major changes in either of the genes analyzed were discovered, only single point mutations that may influence the virus ability to cause disease [6, 40, 41] .

Recently, several virulence factors of HEV have been identified (i.e., ORF1, E3, and fib knob domain) [40] . Although some of the functions of these virulence factors remain to be discovered, there are speculations on their functions. For instance, the protein coded by the ORF1, resembles bacterial sialidases, a group of enzymes that cleave glycosydic linkages of neuraminic acids [60] . These proteins may act as virulence factors for microbial [61, 62] and viral infections [63, 64] ; and may control HEV interactions with host cellular components and, thus, have an effect on pathogenicity and virulence [2] . Interestingly, the product of ORF1 a sialidase, has been recently confirmed as an structural component in the THEV virion, which opens the need for further research on its potential function in the virion [65, 66] . Although the E3 gene shares minimal sequence homology with other adeno viruses outside the genus Siadenovirus, it seems to resemble the E1A protein of Mastadenoviruses and may code for a transcriptional regulator, this based on the cysteine-rich regions resembling the zinc-binding CR3 domain present in E1A from Mastadenovirus [40, 65] . The expression pattern of E3 suggests a possible function in the virus life cycle but its function has not been fully elucidated [65] . The non-synonymous mutations found on the hexon gene are speculated to be in the base of the trimeric hexon protein, perhaps close to the penton with little to no exposure to the host, thus with apparent little importance for antigenicity or pathogenicity. However, according to research conducted on HAdV2 and HAdV5, the area below the protein is important in pH-dependent conformational change of the capsid within the endosome, leading to penetration of the membrane and release of the virus genome into the cytoplasm [54, 55, 57, 58] . Furthermore, upon analysis of 15 HAdV, Crawford-Miksza et al. [57] detected seven hyper variable regions (HVR), from which HVR-1 has a segment that can be found buried in the protein, interacting with the base of the protein. This HAdV HVR-1 has been hypothesized to have an effect on pH-dependent disassembly [55, 58] . Further research is needed, including a sound 3D structure imaging of the HEV hexon protein to provide more evidence to this hypothesis.

The fib knob is implicated in the attachment to the host receptor and it is the only adenoviral protein that is glycosylated [40] ; thus, an alteration of the amino acid sequence may alter the glycosylation of the protein, resulting in increased infectivity and/or decrease virus neutralization thus modifying the virulence of the virus [40, 67] . Interestingly, differences in software-predicted O-linked and N-linked glycosylation areas were witnessed between vaccine/vaccine-like HEV sequences and field HEV sequences; one extra O-linked glycosylation site; and different N-linked profiles. It is worth noting that these software-predicted glycosylation sites would have to be confirmed with relevant techniques, such as liquid chromatography-mass spectrometry (LC-MS/MS) experiments, and that glycosylation patterns vary in different host cell types. Because of the wide different glycosylation scores found in the field HEV sequences, it can be possible that different glycosylation profiles occur between sequences, as some potential sites might be inefficiently glycosylated or miss the chance of post-translational modification [68] . As described before, the proteins relevant for inducing neutralizing antibodies are the hexon protein, and the fiber protein. Although HEV is considered as one serotype, and there is cross-protection between isolates, it is known for some years that there are differences in monoclonal antibodies profiles between avirulent strains (splenic vaccine) and virulent strains (Virulent-IL-1998) [69] . Research in the location of specific antigenic sites for HEV is scarce; however, recent research by Singh et al. 2015 , found a crucial difference between the Fib knob domain structures of avirulent (splenic vaccine-GenBank AY849321), and virulent virus (Virulent-IL-1998-AF074946). In short, they found that non-synonymous mutations M65I (at the C'C"-loop), and M87T located (C'-strand) were responsible for a difference of 3Å upwards in the C'C"loop, changing the configuration of the protein. In the present work, we found changes on the same area (R72S, and L84F on sequences 17-0699-BC-2017; 18-0723-BC-2018; and 18-0665-AB-2018), as well as others that also may cause further change in the 3-D configuration of the protein, however, further crystallography studies would have to be conducted ( Figure 5 ).

The existence of HEV variants in vaccinated flocks with subclinical infections has also been shown [41] . In agreement with the later study, we showed that turkey farms with recurrent morbidities (e.g., systemic bacterial infections, cellulitis, and elevated mortality), with or without HEV vaccination, have subclinical HEV infections caused by HEV different from vaccine strains. Our objective was to characterize these HEV-positive samples based on whole genome sequencing and/or gene sequences (i.e., hexon, ORF1, E3, and fib knob domain).

Following analysis of previously published virulence factors ORF1, E3, and Fib knob [40] as well as the hexon gene, only two out of nine analyzed sequences were deemed tissue culture vaccine-like strains (one sequence obtained from a vaccinated flock, and the other one from a non-vaccinated flock); while seven out of nine were classified as field strain (three sequences obtained from vaccinated flocks, and the other four from non-vaccinated flocks) ( Table 3) . Although all flocks present in this study were suspected to have an immunosuppression component, due to a perceived increased susceptibility to secondary bacterial infections [11] , it is interesting to note that out of four sequences obtained from HE-vaccinated flocks and with secondary bacterial infections (e.g., cellulitis, systemic bacterial infection, and gangrenous dermatitis) (18-0430; 18-0665; 18-0943; and 18-0988) ( Table 1) , three were classified as HEV field virus with no recovery of any vaccine sequence. Recovery of a vaccine sequence was expected after successful HE vaccination in these farms as vaccine is expected to reduce clinical signs, but not virus infection ( Table 3 ). The absence of vaccine-like sequences in these vaccinated flocks, and the presence of field sequences may be considered as evidence suggestive of a vaccine failure scenario. Insufficient vaccine-induced immunity or failure to persistently infect the vaccinated turkeys may be due to genomic changes increasing the virulence of field strains that are able to escape the Viruses 2020, 12, 941 20 of 25 immunity provided by the vaccine or to infect the poults amidst presence of maternal antibodies before vaccination, or perhaps poor vaccine delivery.

Unlike previous research conducted on virulent and avirulent (commercial splenic) sequences [40] , in the present work there were five unique amino acid changes conserved in tissue culture vaccine and vaccine-like sequences distributed in two proteins: (1) the hexon protein (1 aa change) and (2) pTP (4 aa mutations). Variations on the hexon gene were only found in one previous paper by Giovanardi, et al. [12] describing insufficient immunity generated by a commercially-available inactivated splenic vaccine used in Italy. The presence of alterations in amino acid sequence in the pTP protein in tissue culture vaccine and vaccine-like sequences may be related to its passage in cell culture system, as the pTP protein is involved in viral replication forming a heterodimer involving AdPol and functions as a protein primer [70] . It is unclear if these aa changes in pTP would influence the replication rate of a given virus under field conditions, but pTP and hexon protein changes can be powerful markers for identifying tissue culture vaccine-like strains. Furthermore, many novel non-synonymous mutations were observed upon analysis of the Fib, interestingly, in Canadian field-HEV sequences, these amino acid changes were found in close proximity with other amino acid changes also detected in virulent sequences from Israel and US, suggesting that these mutations are located in functional important locations, perhaps areas targeted by the host immune system. Given that HEV neutralizing antibodies are generated against the hexon and fiber knob proteins, any non-synonymous mutation is potentially important as it may interfere with the induction of immunity induced by vaccines and/or increased virulence of wild type HEV strains [41] . However, it is unclear if these differences in hexon, ORF1, and E3 are responsible for the reported superior immunity strength conferred by splenic vaccines when compared with tissue cultured vaccines [8, 36] . It is worth considering that tissue culture vaccines have been manufactured in the 1980s from the Domermuth strain originally used for splenic vaccination since 1970s and that fib knob sequences between these strains are identical [35, 37, 71] . Like previous research on the ORF1 protein, non-synonymous mutations tend to cluster at the terminal portions of ORF1 but in E3, most of the Canadian HEV sequences differ from tissue culture vaccines at location amino acid 173 E3, and a more reduced group of sequences at aa27. These non-synonymous mutations were not only located half way of the E3 protein (aa167, aa146, and aa173) as previous findings [40] , but also, at the beginning (aa27) and towards the end of the protein (aa239) which may suggest other biological important areas within the protein. Changes in these two proteins, the sialidase coded by ORF1 and E3, have been hypothesized to modulate virulence by triggering inflammatory shock responses causing intestinal lesions and mortality due to an inability to cause apoptosis [40] .

The potential efficacy of a given vaccine is determined by the antigenic similarity of the viruses (vaccine and wild type) involved and the neutralization titer generated by the vaccine towards the wild type virus. In general, double-stranded DNA viruses, such as HEV, have the lowest viral mutation rate (ranging between 2 × 10 −7 to 9.8 × 10 −8 substitutions per nucleotide per cell infection) [72, 73] . HEV studies have found no major deletions, insertions nor evidence of recombination between viral sequences; grouping of isolates has occurred based on single point mutations discovered within genes of interest such as hexon [12] , and mainly ORF1, E3, and fib knob domain [40, 41] . The main objective of the current study was to characterize HEV-positive spleen samples obtained from clinical cases in turkey flocks in which immunosuppression was suspected, as in the last 10 years there has been an increase in flocks with unusual increased mortality or secondary bacterial infections. These cases were found in turkey meat operations with or without an HEV-vaccination program, which was performed only with commercially available tissue culture HEV vaccines. These vaccines are the only live vaccines authorized in Canada, unlike other parts of North America and Europe which have commercial and autogenous splenic HEV vaccines, as well as HEV inactivated vaccines [6, 8, 12] . Based on field data recollected by PHS and publications by other researchers [40, 41] , it can be suggested that field HEV viruses may have acquire adaptive changes perhaps due to vaccine pressure. Thus, the whole genome sequencing of the HEV present in spleens of clinical samples was important to understand the type of virus (if vaccine-related or not) is the main wild type HEV present in these farms. Proper phylogenetic analysis would give the industry insight on this answer and infer virulence given previous research [40, 41] .

Although the current study yielded valuable data, our samples did not represent the whole meat turkey industry in Canada. We also do not know whether HEV could be recovered from apparently healthy turkey flocks since our focus was to isolate and characterize HEV from clinical samples.

The analysis of the HEV sequences have revealed the circulation of field type HEV strains in Canadian turkey flocks with a history of vaccination as well as no vaccination. These strains may be responsible for seroconversion, instead of low-virulent tissue-culture-origin strains. Results suggest that HEVs variability in the field may not be as low as previously thought, as some sequences suggest that some adaptive changes, perhaps caused by an increased vaccine pressure, have occurred and may induce immune evasion (BC strains-fib knob domain gene). Finally, as this works shows the circulation of field viruses in vaccinated flocks, and the failure to recover such sequences from clinical samples obtained from vaccinated flocks, a revision/audit of current vaccination practices by the poultry industry is recommended.

Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/9/941/s1, Table S1 : Sequence differences in hexon, ORF1, E3, and fib knob domain. 

Hemorrhagic Enteritis and Related Infections

The Complete DNA Sequence and Genome Organization of the Avian Adenovirus, Hemorrhagic Enteritis Virus

A subunit vaccine against hemorrhagic enteritis adenovirus

Structure and Sialyllactose Binding of the Carboxy-Terminal Head Domain of the Fibre from a Siadenovirus, Turkey Adenovirus

Protection of turkeys against haemorrhagic enteritis by monoclonal antibody and hexon immunization

Haemorrhagic enteritis of turkeys-Current knowledge

The immune response of young turkeys to haemorrhagic enteritis virus infection at different levels and sources of methionine in the diet

Adenovirus Infections

Effect of infection of turkeys with haemorrhagic enteritis adenovirus isolate on the selected parameters of cellular immunity and the course of colibacillosis

Haemorrhagic enteritis of turkeys and related infections of pheasants and domestic fowl: A review. World's

Virus-induced immunosuppression in turkeys (Meleagris gallopavo): A review

Longitudinal field studies of Avian Metapneumovirus and Turkey Hemorrhagic Enteritis Virus in turkeys suffering from colibacillosis associated mortality

Studies concerning the role of Hemorrhagic Enteritis Virus in the pathology of turkeys conducted in the Department of Poultry Diseases in Olsztyn over the last 30 years

Infectious bursal disease and hemorrhagic enteritis

Clinical aspects of immunosuppression in poultry

Transmission of marble spleen disease in turkeys and pheasants

Lesions of Hemorrhagic Enteritis

Hemorrhagic Enteritis of Turkeys

Experimental transmission of haemorrhagic enteritis of turkeys

Persistent Infection of Turkeys with an Avirulent Strain of Turkey Hemorrhagic Enteritis Virus

Effect of Chlorine on the Virus of Hemorrhagic Enteritis of Turkeys

Effect of Disinfectants and Drying on the Virus of Hemorrhagic Enteritis of Turkeys

Pathogenesis of Marble Spleen Disease in Bursectomized and Non-Bursectomized Ring-Necked Pheasants Following Oral Inoculation with Cell-Culture-Propagated Virus

Pathogenesis of Hemorrhagic Enteritis Virus Infection in Turkeys

Comparative pathogenesis of haemorrhagic enteritis virus (HEV) infection in Turkeys and chickens

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

Pathogenic avian adenovirus type II induces apoptosis in turkey spleen cells

Immunopathogenesis of haemorrhagic enteritis virus (HEV) in turkeys

Field Outbreaks of Colibacillosis of Turkeys Associated with Hemorrhagic Enteritis Virus

Colibacillosis of turkeys exacerbated by hemorrhagic enteritis virus. Laboratory studies

A complete protocol for whole-genome sequencing of virus from clinical samples: Application to coronavirus OC43

Further Studies on in vitro and in vivo Assays of Hemorrhagic Enteritis Virus (HEV)

Propagation of Group II Avian Adenoviruses in Turkey and Chicken Leukocytes

Vaccination for Hemorrhagic Enteritis of Turkeys

Improved immunoprophylaxis against Haemorrhagic Enteritis Virus (HEV) in turkeys with repeated drinking water vaccination

Evaluation of cell culture propagated and in vivo propagated hemorrhagic enteritis vaccines in turkeys

Canada's Poultry and Egg Industry Profile

US Turkey Production Falls by 5% in 2019

Comparison of 12 turkey hemorrhagic enteritis virus isolates allows prediction of genetic factors affecting virulence

Molecular Characterization of Hemorrhagic Enteritis Viruses (HEV) Detected in HEV-Vaccinated Commercial Turkey Flocks in Germany

Technical Guide for Hybrid Turkeys Commercial Products; Hybrid Turkeys

Avian Disease Manual

Real-time PCR-based infectivity assay for the titration of turkey hemorrhagic enteritis virus, an adenovirus, in live vaccines

Caveolin-1 Is Not Essential for Biosynthetic Apical Membrane Transport

Optiprep Application Sheet V07-Purification of Group I (ds)DNA Viruses: Adenovirus and Removal of Helper Virus

Real Time PCR-Based Infectivity Assay and Characterization of Cell Surface Receptors for Turkey Hemorrhagic Enteritis Virus

Detection of Chicken and Turkey Meat in Meat Mixtures by Using Real-Time PCR Assays

Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data

A novel method for rapid multiple sequence alignment based on fast Fourier transform

MAFFT multiple sequence alignment software version 7: Improvements in performance and usability

RAxML version 8: A tool for phylogenetic analysis and post-analysis of large phylogenies

Nanoporous crystals of chicken embryo lethal orphan (CELO) adenovirus major coat protein, hexon

Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods

Type-Specific Epitope Locations Revealed by X-Ray Crystallographic Study of Adenovirus Type 5 Hexon

Chapter

Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues

Difference imaging of adenovirus: Bridging the resolution gap between X-ray crystallography and electron microscopy

Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence

Characterization of Avirulent Turkey Hemorrhagic Enteritis Virus: A Study of the Molecular Basis for Variation in Virulence and the Occurrence of Persistent Infection

Structural characterization of the carbohydrate-binding module of NanA sialidase, a pneumococcal virulence factor

The sialidase gene from Clostridium septicum: Cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins

A Study of the Active Site of Influenza Virus Sialidase: An Approach to the Rational Design of Novel Anti-influenza Drugs

Factors promoting pathogenicity of influenza virus

In vitro growth kinetics and gene expression analysis of the turkey adenovirus 3, a siadenovirus

Proteomic analysis of purified turkey adenovirus 3 virions

Fiber Genes of Adenoviruses with Tropism for the Eye and the Genital Tract

Identification of N-linked glycosylation sites in the spike protein and their functional impact on the replication and infectivity of coronavirus infectious bronchitis virus in cell culture

Characterization of group II avian adenoviruses with a panel of monoclonal antibodies

Role of preterminal protein processing in adenovirus replication

Field Vaccination against Hemorrhagic Enteritis of Turkeys by a Cell-Culture Live-Virus Vaccine

Mechanisms of viral mutation

Viral Mutation Rates

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license

The authors also want to acknowledge the help and contribution of Brenda Ralston for her help as liaison within Institute of Applied Poultry Technologies (IAPT) and the Beef Microbiology Laboratory the laboratory located at Alberta Agriculture and Forestry-Airdrie Centre (Airdrie, AB T4A 2K4, Canada). Special thanks to Chantale Provost, Department of Pathology and Microbiology, University of Montreal, and Holly Sellers, Poultry Diagnostic and Research Center, University of Georgia, USA for their continuing mentoring and help with this project.

The authors declare no conflict of interest.